Structural Studies of RyR Channel
RyR通道的结构研究
基本信息
- 批准号:8507907
- 负责人:
- 金额:$ 20.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-03-01 至 2015-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Type 1 ryanodine receptor (RyR1) is an intracellular ligand-gated Ca2+ release channel in skeletal muscle where it is responsible for the increase of free cytoplasmic Ca2+ concentration leading to muscle contraction. Defects in this key protein or in modulation of its activity cause aberrant Ca2+ mobilization from the sarcoplasmic reticulum resulting in several muscle disorders such as Malignant Hyperthermia, Central Core and Multi-minicore Diseases. Lack of high-resolution structure of RyR1 currently limits our ability to understand how this channel functions both in native and disease states. The structural analysis of RyRs is exceptionally challenging due to their large size (~2.3 MDa), location in the membrane environment and dynamic nature. To date, single particle cryo-EM is the most viable methodology for structural analysis of such large integral membrane proteins. However, cryo-EM studies of RyRs confront an additional hurdle due to the presence of detergent in cryospecimen. This raises a number of issues with optimization of ice thickness and EM imaging to produce images with a good contrast for reliable 3D reconstruction. The reduced image contrast is the main impediment to producing high-resolution structures of membrane proteins in general. Achieving a high- resolution structure of RyR1 by cryo-EM clearly requires a breakthrough in methodology for cryo-specimen preparation and imaging conditions. In this project, we aim to develop a method for vitrification of RyR1 for single particle cryo-EM analysis that utilizes the use of a new class of surfactants, amphipathic polymers, in place of detergent to
keep the channel protein soluble and in its functional form in aqueous detergent-free solution (aim1). By using this approach we anticipate to circumvent detergent-imposed difficulties in cryo-EM studies and to achieve the 3D reconstruction of RyR1 in a closed state at subnanometer resolution. We then propose to reconstitute RyR1 channel into small unilamellar vesicles and to use a variant of single particle reconstruction to solve the channel structure in the lipid membrane (aim 2). New computational tools will be developed for this project within the framework of EMAN/EMAN2 software in order to achieve the structure of intact RyR1 at resolutions beyond the current ~1 nm and to establish its 3D architecture in membrane environment. The determined structures will reveal mechanistically informative protein features that will allow important insights into RyR1 channel function. Once optimal methodologies are established, we anticipate to extend the structural analysis of RyR1 to near-atomic resolution and to different physiologically relevant functional states. The methods developed, as part of this research, will have broad applicability to studies of other ion channels and large membrane protein complexes in near-native state.
描述(由申请人提供):1型Ryanodine受体(RYR1)是骨骼肌中的细胞内配体门控Ca2+释放通道,在该通道中,它负责增加自由细胞质Ca2+浓度,从而导致肌肉收缩。该关键蛋白质的缺陷或对其活性的调节导致肌浆网的异常CA2+动员,导致多种肌肉疾病,例如恶性高温,中心核心和多米尼科氏病。当前,缺乏RYR1的高分辨率结构限制了我们了解该渠道在天然和疾病状态中如何发挥作用的能力。 RYR的结构分析由于其尺寸较大(〜2.3 MDA),位于膜环境和动态性质而异常具有挑战性。迄今为止,单个粒子冷冻EM是对这种大型整合膜蛋白结构分析的最可行的方法。然而,由于冰冻膜中存在洗涤剂,对Ryrs的冷冻EM研究面临着另一个障碍。这引发了许多问题,并优化了冰厚度和EM成像,以产生与可靠的3D重建相对鲜明对比的图像。减少的图像对比度是总体上产生膜蛋白高分辨率结构的主要障碍。通过冷冻EM实现RYR1的高分辨率结构,显然需要在冷冻特异性制备和成像条件的方法中取得突破。在该项目中,我们旨在开发一种用于使用新的表面活性剂,两亲聚合物的单个粒子冷冻EM分析的RYR1玻璃化方法,并代替洗涤剂
将通道蛋白溶于及其功能形式保持在无水清洁剂溶液中(AIM1)。通过使用这种方法,我们预计在冷冻EM研究中会绕过清洁剂的困难,并在封闭状态下以亚纳米分辨率在封闭状态下实现RYR1的3D重建。然后,我们建议将RYR1通道重建为小的单层囊泡,并使用单个颗粒重建的变体来求解脂质膜中的通道结构(AIM 2)。将在EMAN/EMAN2软件的框架内为该项目开发新的计算工具,以实现超出当前〜1 nm的分辨率的完整RYR1的结构,并在膜环境中建立其3D体系结构。确定的结构将揭示机械信息丰富的蛋白质特征,这将允许对RYR1通道功能的重要见解。一旦建立了最佳方法论,我们预计将RYR1的结构分析扩展到近原子分辨率,并扩展到不同生理相关的功能状态。作为这项研究的一部分,开发的方法将对其他离子通道和近膜蛋白复合物的研究具有广泛的适用性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Irina I Serysheva的其他基金
Defining architecture of EC coupling machinery in situ
现场定义 EC 耦合机械的架构
- 批准号:1071122310711223
- 财政年份:2023
- 资助金额:$ 20.58万$ 20.58万
- 项目类别:
ACQUISITION OF HIGH-THROUGHPUT 200 kV CRYO-TEM
获取高通量 200 kV 冷冻透射电镜
- 批准号:1041565010415650
- 财政年份:2022
- 资助金额:$ 20.58万$ 20.58万
- 项目类别:
Structural Studies of RyR Channel
RyR通道的结构研究
- 批准号:86275478627547
- 财政年份:2013
- 资助金额:$ 20.58万$ 20.58万
- 项目类别:
INOSITOL 1,4,5 TRIPHOSPHATE RECEPTOR (IP3R)
肌醇 1,4,5 三磷酸受体 (IP3R)
- 批准号:83610628361062
- 财政年份:2011
- 资助金额:$ 20.58万$ 20.58万
- 项目类别:
INOSITOL 1,4,5 TRIPHOSPHATE RECEPTOR (IP3R)
肌醇 1,4,5 三磷酸受体 (IP3R)
- 批准号:81685328168532
- 财政年份:2010
- 资助金额:$ 20.58万$ 20.58万
- 项目类别:
Structural type 1 inositol 1,4,5-trisphosphate receptor
结构类型 1 肌醇 1,4,5-三磷酸受体
- 批准号:80178798017879
- 财政年份:2010
- 资助金额:$ 20.58万$ 20.58万
- 项目类别:
INOSITOL 1,4,5 TRIPHOSPHATE RECEPTOR (IP3R)
肌醇 1,4,5 三磷酸受体 (IP3R)
- 批准号:79537607953760
- 财政年份:2008
- 资助金额:$ 20.58万$ 20.58万
- 项目类别:
INOSITOL 1,4,5 TRIPHOSPHATE RECEPTOR (IP3R)
肌醇 1,4,5 三磷酸受体 (IP3R)
- 批准号:77211317721131
- 财政年份:2007
- 资助金额:$ 20.58万$ 20.58万
- 项目类别:
INOSITOL 1,4,5 TRIPHOSPHATE RECEPTOR (IP3R)
肌醇 1,4,5 三磷酸受体 (IP3R)
- 批准号:75985897598589
- 财政年份:2006
- 资助金额:$ 20.58万$ 20.58万
- 项目类别:
Structure-function studies of IP3R channels
IP3R通道的结构功能研究
- 批准号:85756138575613
- 财政年份:2005
- 资助金额:$ 20.58万$ 20.58万
- 项目类别:
相似国自然基金
基于祖先序列重构的D-氨基酸解氨酶的新酶设计及分子进化
- 批准号:32271536
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
模板化共晶聚合合成高分子量序列聚氨基酸
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
模板化共晶聚合合成高分子量序列聚氨基酸
- 批准号:22201105
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于祖先序列重构的D-氨基酸解氨酶的新酶设计及分子进化
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
C-末端40个氨基酸插入序列促进细菌脂肪酸代谢调控因子FadR转录效率的机制研究
- 批准号:82003257
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
相似海外基金
Programmable peptide-guided protein degradation
可编程肽引导的蛋白质降解
- 批准号:1074165510741655
- 财政年份:2023
- 资助金额:$ 20.58万$ 20.58万
- 项目类别:
Characterizing the role of tumor suppressor phase separation and chromatin organization in maintaining genomic integrity
表征肿瘤抑制相分离和染色质组织在维持基因组完整性中的作用
- 批准号:1072373910723739
- 财政年份:2023
- 资助金额:$ 20.58万$ 20.58万
- 项目类别:
Exploiting public genomic and transcriptomic data to uncover cancer-RNA editing relationships
利用公共基因组和转录组数据揭示癌症-RNA 编辑关系
- 批准号:1045386710453867
- 财政年份:2022
- 资助金额:$ 20.58万$ 20.58万
- 项目类别:
Exploiting public genomic and transcriptomic data to uncover cancer-RNA editing relationships
利用公共基因组和转录组数据揭示癌症-RNA 编辑关系
- 批准号:1064394910643949
- 财政年份:2022
- 资助金额:$ 20.58万$ 20.58万
- 项目类别:
A Microphysiological Mimicry of Human Lung-Bone Marrow Organ-Organ Crosstalk On-a-Chip
芯片上人体肺-骨髓器官-器官串扰的微生理模拟
- 批准号:1046873610468736
- 财政年份:2021
- 资助金额:$ 20.58万$ 20.58万
- 项目类别: